- Home
- BLIN vs HOTH Comparison
BLIN vs HOTH Comparison
Compare BLIN & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- HOTH
- Stock Information
- Founded
- BLIN 2000
- HOTH 2017
- Country
- BLIN United States
- HOTH United States
- Employees
- BLIN N/A
- HOTH N/A
- Industry
- BLIN EDP Services
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- BLIN Technology
- HOTH Health Care
- Exchange
- BLIN Nasdaq
- HOTH Nasdaq
- Market Cap
- BLIN 15.9M
- HOTH 18.0M
- IPO Year
- BLIN 2007
- HOTH 2019
- Fundamental
- Price
- BLIN $0.95
- HOTH $1.16
- Analyst Decision
- BLIN Strong Buy
- HOTH Strong Buy
- Analyst Count
- BLIN 1
- HOTH 2
- Target Price
- BLIN $4.62
- HOTH $4.50
- AVG Volume (30 Days)
- BLIN 48.5K
- HOTH 316.4K
- Earning Date
- BLIN 12-22-2025
- HOTH 11-12-2025
- Dividend Yield
- BLIN N/A
- HOTH N/A
- EPS Growth
- BLIN N/A
- HOTH N/A
- EPS
- BLIN N/A
- HOTH N/A
- Revenue
- BLIN $15,375,000.00
- HOTH N/A
- Revenue This Year
- BLIN $2.45
- HOTH N/A
- Revenue Next Year
- BLIN $16.36
- HOTH N/A
- P/E Ratio
- BLIN N/A
- HOTH N/A
- Revenue Growth
- BLIN 0.54
- HOTH N/A
- 52 Week Low
- BLIN $0.90
- HOTH $0.66
- 52 Week High
- BLIN $2.80
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- BLIN 25.25
- HOTH 38.64
- Support Level
- BLIN $0.90
- HOTH $1.14
- Resistance Level
- BLIN $1.00
- HOTH $1.22
- Average True Range (ATR)
- BLIN 0.07
- HOTH 0.08
- MACD
- BLIN -0.02
- HOTH -0.01
- Stochastic Oscillator
- BLIN 10.92
- HOTH 38.57
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).